Drug repurposing—an emerging strategy in cancer therapeutics Khadija Shahab TurabiAnkita DeshmukhJyotirmoi Aich Review 13 June 2022 Pages: 1139 - 1158
Pandemic COVID-19, an update of current status and new therapeutic strategies Antonio VitielloRaffaele La PortaMariarosaria Boccellino Review 02 July 2022 Pages: 1159 - 1165
RETRACTED ARTICLE: Ameliorative effect of two structurally divergent hydrazide derivatives against DSS-induced colitis by targeting Nrf2 and NF-κB signaling in mice Ashrafullah KhanAdnan KhanSalman Khan Original Article 19 July 2022 Pages: 1167 - 1188
Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats Himanshu VermaAnindita BhattacharjeePrasanta Kumar Nayak Original Article 25 July 2022 Pages: 1189 - 1207
Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS Wendi LiShanshan LiMing Su Original Article 26 July 2022 Pages: 1209 - 1224
[1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice Amr Ahmed WalyEldeenHaidan M. El-ShorbagySherif Abdelaziz Ibrahim Original Article Open access 26 July 2022 Pages: 1225 - 1238
Peripheral tissular analysis of rapamycin’s effect as a neuroprotective agent in vivo Alfredo Gonzalez-AlcocerYareth Gopar-CuevasAracely Garcia-Garcia Original Article 27 July 2022 Pages: 1239 - 1255
β1- and β1/β2-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens Antonio Tiago LimaAmanda Consulin AmorimGilberto De Nucci Research 08 July 2022 Pages: 1257 - 1268
Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model Felipe Fagundes LeãoAna Paula Farias WaltrickJanaina Menezes Zanoveli Research 19 July 2022 Pages: 1269 - 1282
Luteolin-7-O-rutinoside from Pteris cretica L. var. nervosa attenuates LPS/D-gal-induced acute liver injury by inhibiting PI3K/AKT/AMPK/NF-κB signaling pathway Ziwei XiongYushun CuiYulin Feng Research 26 July 2022 Pages: 1283 - 1295